CommentaryAzodicarbonamide (cas 123-77-3) (ADCA): A reconsideration of classification as a respiratory sensitiser

Add time:09/26/2019    Source:sciencedirect.com

Azodicarbonamide (ADCA) is widely used by industry in the manufacture of a variety of products. ADCA has been classified as a respiratory allergen, and the purpose of this article was to consider whether this classification is appropriate based upon the available data. Here both clinical experience and relevant experimental data have been reviewed. Although there have been reports of an association between workplace exposure to ADCA and symptoms of respiratory allergy and occupational asthma, the evidence is less than persuasive, with in many instances a lack of properly controlled and executed diagnostic procedures. In addition, ADCA fails to elicit positive responses in mouse and guinea pig predictive tests for skin sensitisation; a lack of activity that is regarded as being inconsistent with respect to respiratory sensitising potential. Collectively, the data reviewed here do not provide an adequate basis for the classification of ADCA as a respiratory allergen.

We also recommend Trading Suppliers and Manufacturers of Azodicarbonamide (cas 123-77-3). Pls Click Website Link as below: cas 123-77-3 suppliers

Prev:Ribonucleotide reductase and thymidine phosphorylation: two potential targets of Azodicarbonamide (cas 123-77-3)
Next:Test methodNon-isothermal decomposition kinetics of Azodicarbonamide (cas 123-77-3) in high density polyethylene using a capillary rheometer)